Last €1.20 EUR
Change Today +0.014 / 1.18%
Volume 0.0
As of 9:34 AM 01/23/15 All times are local (Market data is delayed by at least 15 minutes).

escalon medical corp (ES4) Snapshot

Open
€1.24
Previous Close
€1.19
Day High
€1.24
Day Low
€1.20
52 Week High
01/27/14 - €1.64
52 Week Low
03/20/14 - €0.97
Market Cap
9.1M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
7.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ESCALON MEDICAL CORP (ES4)

Related News

No related news articles were found.

escalon medical corp (ES4) Related Businessweek News

No Related Businessweek News Found

escalon medical corp (ES4) Details

Escalon Medical Corp. develops, manufactures, markets, and distributes ophthalmic medical devices and pharmaceuticals in the United States and Europe. It provides A-Scans, which provide information about the internal structure of the eye; B-Scans that are diagnostic tools, which supplies information to physicians where the media in the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device to provide detailed information about the anterior segment of the eye; and pachymeters, which measure the thickness of cornea. The company also offers color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; and Ispan intraocular gases which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery, as well as a patented disposable universal gas kit that delivers the gas from the canister to the patient. In addition, it provides viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil; light source and fiber optic products that are used by vitreoretinal surgeons during surgery; and AXIS image management system for managing images through the Web from various devices regardless of modality, manufacturer, or location. The company sells its products primarily to teaching institutions, hospitals, and eye surgery centers through internal sales employees and independent sales representatives. Escalon Medical Corp. was founded in 1987 and is based in Ardmore, Pennsylvania.

58 Employees
Last Reported Date: 09/26/14
Founded in 1987

escalon medical corp (ES4) Top Compensated Officers

Chief Executive Officer, President, General C...
Total Annual Compensation: $215.0K
Chief Financial Officer
Total Annual Compensation: $212.6K
Chief Operating Officer
Total Annual Compensation: $175.0K
Compensation as of Fiscal Year 2014.

escalon medical corp (ES4) Key Developments

Escalon Medical Corp. Reports Consolidated Earnings Results for the First Quarter Ended September 30, 2014

Escalon Medical Corp. reported consolidated earnings results for the first quarter ended September 30, 2014. For the quarter, the company reported a net loss of $458,959 and a net loss from continuing operations of $440,196, or $0.06 per share. This compares to net income of $13,241 for the first quarter of fiscal 2014 and net income from continuing operations of $38,846. Revenues, net were $2,630,320 against $3,130,083 for the same period a year ago. Loss from operations was $440,235 against profit from operations of $37,717 for the same period a year ago. Loss from continuing operations was $440,196 or $0.06 per basic and diluted share against income from continuing operations of $38,846 or $0.00 per basic and diluted share for the same period a year ago.

Escalon Medical Corp., Annual General Meeting, Dec 23, 2014

Escalon Medical Corp., Annual General Meeting, Dec 23, 2014., at 09:00 US Eastern Standard Time. Location: 435 Devon Park Drive, Building 100. Agenda: To elect two class III directors, each for a term of three years and until their respective successors have been elected to serve; to ratify the selection of Mayer Hoffman McCann P.C. as the company's independent registered public accounting firm for the fiscal year ending June 30, 2015; and to discuss any other matters that properly come before annual meeting.

Escalon Medical Corp. Reports Un-Audited Consolidated Earnings Results for the Year Ended June 30, 2014

Escalon Medical Corp. reported un-audited consolidated earnings results for the year ended June 30, 2014. For the year, the company reported a net loss of $381,883 or $0.05 per share and a net loss from continuing operations of $349,532, or $0.05 per share. This compares to net income of $2.6 million, or $0.35 per share, for fiscal 2013, which includes a net gain of $3.9 million related to the sale of Drew and related debt settlement. The net loss from continuing operations was $1.2 million, or $0.16 per share, for fiscal 2013. The company reported revenue, net of $12.4 million compared to $11.5 million and loss from operations of $0.4 million compared to $1.2 million for the last year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ES4:GR €1.20 EUR +0.014

ES4 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ES4.
View Industry Companies
 

Industry Analysis

ES4

Industry Average

Valuation ES4 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book 3.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ESCALON MEDICAL CORP, please visit www.escalonmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.